<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00772291</url>
  </required_header>
  <id_info>
    <org_study_id>pregabalin RCT</org_study_id>
    <nct_id>NCT00772291</nct_id>
  </id_info>
  <brief_title>Chronic Pain Management After Herniorraphy</brief_title>
  <acronym>pregabalin</acronym>
  <official_title>Chronic Pain Management After Herniorraphy:Pregabalin vs Placebo. A Double-blinded Randomised Controlled Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasmus Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasmus Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays, chronic pain mainly as a result of iatrogenic nerve damage is generally considered&#xD;
      as the most frequent complication after inguinal hernia surgery. The primary objective of&#xD;
      this randomised double-blind placebo-controlled trial is to investigate whether pregabalin&#xD;
      reduces pain in patients with chronic pain of neuropathic origin after herniorraphy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>quantitative sensory testing (QST) accuracy in testing the inguinal region</measure>
    <time_frame>8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>pregabalin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pregabalin</intervention_name>
    <description>pregabalin 150-600mg/day during 8 weeks</description>
    <arm_group_label>pregabalin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo drug during 8 weeks</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. History of unilateral inguinal herniotomy&#xD;
&#xD;
          2. Establishment of neuropathic character of chronic pain by means the LANSS painscore&#xD;
             and DN4 score&#xD;
&#xD;
          3. Abnormal sensitivity (allodynia, dysesthesia, hypoesthesia or dysesthesia) in or&#xD;
             around the incisional area&#xD;
&#xD;
          4. Duration pain ≥ 3 months&#xD;
&#xD;
          5. Medial or lateral inguinal hernia&#xD;
&#xD;
          6. Age ≥ 18 years&#xD;
&#xD;
          7. VAS score ≥ 40 mm on Vas scale on which they indicate 'how unpleasant or disturbing&#xD;
             the worst pain was that they had today'&#xD;
&#xD;
          8. Grade III or IV pain and discomfort on the 4-point pain and discomfort scale&#xD;
&#xD;
          9. Informed consent (addendum V)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participation in another trial&#xD;
&#xD;
          2. Age &lt; 18 years&#xD;
&#xD;
          3. Cognitive disfunction&#xD;
&#xD;
          4. Patient is unable to speak Dutch&#xD;
&#xD;
          5. Hereditary problems of galactose intolerance, Lapp lactase deficiency or&#xD;
             glucosegalactose malabsorption&#xD;
&#xD;
          6. Patient classified as American Society of Anaesthesiologist Class 4&#xD;
&#xD;
          7. Renal impairment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J.F. Lange, professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erasmus Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015CE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <study_first_submitted>October 13, 2008</study_first_submitted>
  <study_first_submitted_qc>October 14, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2008</study_first_posted>
  <last_update_submitted>August 18, 2011</last_update_submitted>
  <last_update_submitted_qc>August 18, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 19, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Erasmus Medical Center</investigator_affiliation>
    <investigator_full_name>hasan eker</investigator_full_name>
    <investigator_title>Prof. Dr. J.F. Lange</investigator_title>
  </responsible_party>
  <keyword>inguinal</keyword>
  <keyword>hernia</keyword>
  <keyword>chronic</keyword>
  <keyword>pain</keyword>
  <keyword>pregabalin</keyword>
  <keyword>chronic pain after inguinal herniorraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pregabalin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

